363250 — Genesystem Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual income statement for Genesystem Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	13,258	13,237	3,653	897	1,208
Cost of Revenue
Gross Profit	8,987	8,666	1,167	-1,586	-1,820
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	9,931	10,971	10,258	10,382	11,324
Operating Profit	3,328	2,266	-6,605	-9,484	-10,116
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-3,592	3,165	-7,060	-7,913	-9,679
Provision for Income Taxes
Net Income After Taxes	-2,224	3,551	-8,996	-8,059	-9,529
Minority Interest
Net Income Before Extraordinary Items
Net Income	-2,224	3,551	-8,996	-7,915	-8,915
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-2,224	3,551	-8,996	-7,915	-8,915
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-328	554	-1,303	-1,139	-1,302
Dividends per Share